This review synthesizes current evidence on the interplay between the aryl hydrocarbon receptor (AhR), G protein-coupled receptor 35 (GPR35), cytochrome P450 enzymes, and dietary ligands in the context of inflammatory bowel disease (IBD) and colorectal cancer (CRC). The gene discussed is GPR35; the disease is colorectal cancer.